These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2749476)
41. [Comparison of the T.A.T.I. marker with CEA and Ca 19-9 in neoplasms of the gastrointestinal system. Preliminary data]. Ricci E; Pecchio F; Rapellino M; Giaccone M; Adamo R; Boltri F; Oliaro A Minerva Dietol Gastroenterol; 1988; 34(4):217-20. PubMed ID: 3247053 [No Abstract] [Full Text] [Related]
42. Colon and ovarian tumor antigen in human colon tumors grown in culture and in athymic mice. Zamora PO; Pant KD; Sass K; Barry E; Tabet C; Rhodes BA; Hay R J Natl Cancer Inst; 1986 May; 76(5):977-9. PubMed ID: 3457981 [No Abstract] [Full Text] [Related]
43. [The role of CEA, CA 19-9 and TPA in the diagnosis of pancreatic cancer. Evaluation by discriminant analysis]. Basso D; Fabris C; Del Favero G; Panucci A; Piccoli A; Plebani M; Pedrazzoli S; Baccaglini U; Lise M; Burlina A Minerva Med; 1986 Apr; 77(16):613-6. PubMed ID: 3458035 [TBL] [Abstract][Full Text] [Related]
44. [Biological properties of two newly established cell lines (RMUG-S, RMUG-L) from a human ovarian mucinous cystadenocarcinoma]. Sakayori M; Nozawa S; Udagawa Y; Chin K; Lee SG; Sakuma T; Iizuka R; Wada Y; Yoshida S; Takeda Y Hum Cell; 1990 Mar; 3(1):52-6. PubMed ID: 2083224 [TBL] [Abstract][Full Text] [Related]
45. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267 [TBL] [Abstract][Full Text] [Related]
46. [The value of tumor markers in colorectal cancer]. Peters KM; Grundmann R Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234 [TBL] [Abstract][Full Text] [Related]
47. Establishment of a subcutaneous model of the human extrahepatic bile duct carcinoma in nude mice via transplantation of histologically intact tumor tissue. Tang WH; Yuan ST; Wang BS; Lu LJ; Ding J; Yuan ZR J Exp Clin Cancer Res; 2004 Dec; 23(4):661-7. PubMed ID: 15743037 [TBL] [Abstract][Full Text] [Related]
48. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice. Reyes G; Villanueva A; García C; Sancho FJ; Piulats J; Lluís F; Capellá G Cancer Res; 1996 Dec; 56(24):5713-9. PubMed ID: 8971180 [TBL] [Abstract][Full Text] [Related]
49. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody. Gautherot E; Kraeber-Bodéré F; Daniel L; Fiche M; Rouvier E; Saï-Maurel C; Thedrez P; Chatal JF; Barbet J Clin Cancer Res; 1999 Oct; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361 [TBL] [Abstract][Full Text] [Related]
50. [Serum level of tumor markers (antigen Ca 19-9, CEA, ferritin) in digestive tumors. Their diagnostic usefulness]. Jovin G; Stănel I; Popovici I; Oproiu A Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(3):223-9. PubMed ID: 2904162 [No Abstract] [Full Text] [Related]
51. Morphologic, biologic and biochemical characteristics of three human pancreatic ductal adenocarcinomas established as xenotransplants in the nude mouse. Kyriazis AP; Kyriazis AA In Vivo; 1990; 4(2):137-43. PubMed ID: 1966587 [TBL] [Abstract][Full Text] [Related]
52. Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract. Harmenberg U; Wahren B; Wiechel KL Cancer Res; 1988 Apr; 48(7):1985-8. PubMed ID: 3349472 [TBL] [Abstract][Full Text] [Related]
53. "COLO 357," a human pancreatic adenosquamous carcinoma: growth in artificial capillary culture and in nude mice. Meitner PA; Kajiji SM; LaPosta-Frazier N; Bogaars HA; Jolly GA; Dexter DL; Calabresi P; Turner MD Cancer Res; 1983 Dec; 43(12 Pt 1):5978-85. PubMed ID: 6640542 [TBL] [Abstract][Full Text] [Related]
54. [A fundamental study of immunoscintigraphy with 131I-labeled anti-CA 19-9 and anti-CEA monoclonal antibodies--imaging of tumor-bearing mice by IMACIS-1 and cell ELISA with human tumor cells]. Nogami T; Miura H; Ohmi S; Kazahaya Y Kaku Igaku; 1990 May; 27(5):427-36. PubMed ID: 2395226 [TBL] [Abstract][Full Text] [Related]
55. Kinetics of carcinoembryonic antigen and carbohydrate antigen 19-9 production in a human pancreatic cancer cell line (SUIT-2). Iwamura T; Katsuki T Gastroenterol Jpn; 1987 Oct; 22(5):640-6. PubMed ID: 2445616 [TBL] [Abstract][Full Text] [Related]
56. Combined therapy of xenografts of human pancreatic carcinomas with rTNF-alpha and mitomycin C. Klapdor R; Franke N; Bahlo M Onkologie; 1989 Jun; 12(3):143-7. PubMed ID: 2503798 [TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical localization of CA 19-9 and CEA in pancreatic carcinoma and associated diseases. Ichihara T; Nagura H; Nakao A; Sakamoto J; Watanabe T; Takagi H Cancer; 1988 Jan; 61(2):324-33. PubMed ID: 3422034 [TBL] [Abstract][Full Text] [Related]
58. Carcinoembryonic antigen (CEA) in human colorectal cancers growing subcutaneously in nude mice. Fiebig HH; von Kleist S J Cancer Res Clin Oncol; 1983; 105(3):238-42. PubMed ID: 6853586 [TBL] [Abstract][Full Text] [Related]
59. [Establishment, in nude mice, of a serially transplantable human stomach cancer (KUM X MK-2) producing plural tumor markers--human stomach cancer producing CEA, CA19-9, KM01]. Inufusa H Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2264. PubMed ID: 3469450 [No Abstract] [Full Text] [Related]
60. DU-PAN-2, mucin type differentiation antigen of normal and malignant pancreatic ductal cells. Metzgar RS; Lan MS; Kim YW; Koriwchak MJ; Mullins TD; Hollingsworth MA Prog Clin Biol Res; 1989; 288():53-61. PubMed ID: 2717641 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]